Signaling pathways as therapeutic targets in biliary tract cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Signaling pathways as therapeutic targets in biliary tract cancer

Published:2017-03-17 Issue:5 Volume:21 Page:485-498
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Yang Jennifer¹,Farren Matthew R.²,Ahn Daniel³,Bekaii-Saab Tanios³,Lesinski Gregory B.²

Affiliation:

1. Molecular Cellular and Developmental Biology Graduate Program, The Ohio State University, Columbus, OH, USA

2. Department of Hematology and Medical Oncology, The Winship Cancer Institute of Emory University, Atlanta, GA, USA

3. Division of Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2017.1306055

Reference223 articles.

1. Worldwide trends in mortality from biliary tract malignancies

2. Hepatic Resection in the Treatment of Hilar Cholangiocarcinoma

3. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma

4. Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma

5. Phase II Trial of Docetaxel for Cholangiocarcinoma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PIWI-interacting RNAs (PiRNAs) as emerging biomarkers and therapeutic targets in biliary tract cancers: A comprehensive review;Heliyon;2024-07

2. Sorafenib Chemosensitization by Caryophyllane Sesquiterpenes in Liver, Biliary, and Pancreatic Cancer Cells: The Role of STAT3/ABC Transporter Axis;Pharmaceutics;2022-06-14

3. MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen;Cancers;2022-05-23

4. Modulation of STAT3 Signaling, Cell Redox Defenses and Cell Cycle Checkpoints by β-Caryophyllene in Cholangiocarcinoma Cells: Possible Mechanisms Accounting for Doxorubicin Chemosensitization and Chemoprevention;Cells;2020-04-02

5. Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials;Medicina;2019-02-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3